BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18088560)

  • 21. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study.
    Rodriguez RF; Castillo JM; Del Pilar Castillo M; Nuñez PD; Rodriguez MF; Restrepo JM; Rodriguez JM; Ortiz Y; Angel AM
    Clin Ther; 2007 Apr; 29(4):581-7. PubMed ID: 17617281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain.
    Issa MA; Narang S; Jamison RN; Michna E; Edwards RR; Penetar DM; Wasan AD
    Clin J Pain; 2014 Jun; 30(6):472-8. PubMed ID: 24281276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.
    Hale ME; Ahdieh H; Ma T; Rauck R;
    J Pain; 2007 Feb; 8(2):175-84. PubMed ID: 17145204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
    Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
    Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study.
    Mehlisch DR; Aspley S; Daniels SE; Southerden KA; Christensen KS
    Clin Ther; 2010 Jun; 32(6):1033-49. PubMed ID: 20637958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant use of intravenous lidocaine for procedural burn pain relief: a randomized double-blind, placebo-controlled, cross-over trial.
    Wasiak J; Spinks A; Costello V; Ferraro F; Paul E; Konstantatos A; Cleland H
    Burns; 2011 Sep; 37(6):951-7. PubMed ID: 21497022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.
    de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H;
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee.
    Peloso PM; Bellamy N; Bensen W; Thomson GT; Harsanyi Z; Babul N; Darke AC
    J Rheumatol; 2000 Mar; 27(3):764-71. PubMed ID: 10743822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
    Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
    Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
    Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
    Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies.
    Notcutt W; Price M; Miller R; Newport S; Phillips C; Simmons S; Sansom C
    Anaesthesia; 2004 May; 59(5):440-52. PubMed ID: 15096238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral opioid therapy for chronic peripheral and central neuropathic pain.
    Rowbotham MC; Twilling L; Davies PS; Reisner L; Taylor K; Mohr D
    N Engl J Med; 2003 Mar; 348(13):1223-32. PubMed ID: 12660386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the efficacy and safety profiles of aspirin and acetaminophen with codeine: results from 2 randomized, controlled trials in individuals with tension-type headache and postoperative dental pain.
    Gatoulis SC; Voelker M; Fisher M
    Clin Ther; 2012 Jan; 34(1):138-48. PubMed ID: 22169050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.
    Naef M; Curatolo M; Petersen-Felix S; Arendt-Nielsen L; Zbinden A; Brenneisen R
    Pain; 2003 Sep; 105(1-2):79-88. PubMed ID: 14499423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.